As expected, patients with HCC presenting high HSF2 expression in the TCGA-LIHC and ICGC-LIRI-JP cohorts had a poor prognosis (Supplementary Figures S1B,C). This evidence concerns the gene HSF2 and hepatocellular carcinoma.